| Current Price | $36.37 | Mkt Cap | $5.3B |
|---|---|---|---|
| Open | $37.44 | P/E Ratio | 0.00 |
| Prev. Close | $36.37 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $35.76 - $37.92 | Volume | 962,845 |
| 52-Wk Range | $34.43 - $64.37 | Avg. Daily Vol. | 1,366,434 |
The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.
| Current Price | $36.37 | Mkt Cap | $5.3B |
|---|---|---|---|
| Open | $37.44 | P/E Ratio | 0.00 |
| Prev. Close | $36.37 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $35.76 - $37.92 | Volume | 962,845 |
| 52-Wk Range | $34.43 - $64.37 | Avg. Daily Vol. | 1,366,434 |
The best Bull and Bear pitches based on recency and number of recommendations.
They have a new anticoagulant which in 300 humans, given preoperatively for knee replacement, yielded NO clots (as opposed to 15% for Lovenox) and a bleeding risk of 5%, compared to 8% for Lovenox. This is a game-changer.
Read the most recent pitches from players about IONS.
Recs
TMFAdriaCimino
(26.96)
Submitted: 7/3/2021 6:07:34 PM :
Start Price:
$40.22
NASDAQ:IONS Score:
-10.78
Ionis has several candidates in the pipeline and expects to have at least 12 commercialized products by 2026. If that happens, we can expect a big increase in revenue over the coming years.
Recs
MKWas
(< 20)
Submitted: 2/18/2021 3:01:53 PM :
Start Price:
$57.84
NASDAQ:IONS Score:
-49.36
A leaders in antisense oligonucleotides, an emerging technology used to control messenger RNA .
Recs
IndyAnthony
(77.08)
Submitted: 2/5/2021 11:57:00 PM :
Start Price:
$60.59
NASDAQ:IONS Score:
+52.75
This biotech pharma company has out performed the S&P 500 over the last 10 years by hundreds of percent, but over the last 5 years, IONS has lost to the market by almost 30%, with most of those losses coming in 2020. The Founders are still involved, but institutions own almost 87% of the company. Despite collaborations with Roche, Biogen, and AstraZeneca, I think this company will underperform the market over the next 5-10 years.
Find the members with the highest scoring picks in IONS.
yosemitebean (37.13) Score: +612.44
The Score Leader is the player with the highest score across all their picks in IONS.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| uclajphil6 | < 20 | 1/7/2009 |
|
3W | $13.98 | +160.16% | +392.06% | +231.91 | 0 Comment | |
| JerryDreamer | < 20 | 8/17/2009 |
|
3W | $15.37 | +136.63% | +346.25% | +209.62 | 1 Comment | |
| RXDOC73 | 97.97 |
|
|
NS | $6.59 | +451.90% | +267.68% | +184.22 | 1 Comment | |
| Myshkin69 | < 20 | 11/14/2011 |
|
5Y | $6.99 | +420.31% | +249.86% | +170.45 | 0 Comment | |
| loangolfer | < 20 |
|
|
NS | $6.99 | +420.31% | +250.59% | +169.72 | 0 Comment | |
| Santa22 | < 20 | 9/22/2006 |
|
3Y | $7.02 | +418.09% | +255.02% | +163.07 | 0 Comment | |
| asterionc2 | 74.18 | 9/27/2006 |
|
5Y | $7.10 | +412.25% | +249.27% | +162.98 | 0 Comment | |
| jdmckeehan | < 20 | 10/2/2006 |
|
3Y | $7.18 | +406.55% | +249.01% | +157.54 | 0 Comment | |
| John8464 | < 20 | 9/15/2006 |
|
1Y | $7.23 | +403.04% | +251.04% | +152.00 | 0 Comment | |
| leadtip | < 20 | 8/25/2006 |
|
1Y | $7.09 | +412.98% | +261.19% | +151.79 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
